Vidac Pharma Holding Plc (HAM:T9G)
Germany flag Germany · Delayed Price · Currency is EUR
0.5200
0.00 (0.00%)
At close: Jul 29, 2025

Vidac Pharma Holding Company Description

Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells.

It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that are in preclinical stage for use in the treatment of solid tumors.

The company was incorporated in 2021 and is based in London, the United Kingdom.

Vidac Pharma Holding Plc
CountryUnited Kingdom
Founded2021
IndustryBiological Products, Except Diagnostic Substances
CEOMax Herzberg

Contact Details

Address:
20-22, Wenlock Road
London, N1 7GU
United Kingdom
Phone972 54 4257381
Websitevidacpharma.com

Stock Details

Ticker SymbolT9G
ExchangeHamburg Stock Exchange
Reporting CurrencyEUR
SIC Code2836

Key Executives

NamePosition
Max HerzbergChief Executive Officer
Shuki CohenChief Financial Officer
Sandra GamzonChief Operating Officer